The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms

Phase 2

Completed

Conditions: Ductal Carcinoma in Situ
Estrogen Receptor-positive Breast Cancer
Progesterone Receptor-positive Breast Cancer
Stage I Breast Cancer
Stage II Breast Cancer
Stage IIIA Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer

Interventions: Drug: letrozole
Drug: zoledronic acid

First Posted Date: 2010-09-03

Last Posted Date: 2018-09-12

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 63

Registration Number: NCT01194440

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer

Phase 2

Terminated

Conditions: Stage I Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer
Invasive Breast Cancer

Interventions: Drug: Vorinostat and Tamoxifen

First Posted Date: 2010-09-03

Last Posted Date: 2013-05-17

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 2

Registration Number: NCT01194427

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Phase 2

Terminated

Conditions: Leukemia
Myelodysplastic Syndrome
Lymphoma

Interventions: Drug: Fludarabine
Drug: Busulfan
Drug: Cyclophosphamide
Drug: Mycophenolate Mofetil
Drug: Tacrolimus

First Posted Date: 2010-06-02

Last Posted Date: 2018-07-03

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 15

Registration Number: NCT01135329

Locations: 🇺🇸
The Sydney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

Not Applicable

Completed

Conditions: Prostate Cancer

First Posted Date: 2010-05-07

Last Posted Date: 2018-06-12

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 19

Registration Number: NCT01118741

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Thomas Jefferson Universith, Philadelphia, Pennsylvania, United States
🇺🇸
Duke University, Durham, North Carolina, United States

Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi

Completed

Conditions: Melanoma

First Posted Date: 2010-05-07

Last Posted Date: 2019-02-08

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 30

Registration Number: NCT01118832

Locations: 🇺🇸
Johns Hopkins Medicine, Baltimore, Maryland, United States

Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas

Phase 2

Completed

Conditions: Metastatic Pancreatic Cancer

Interventions: Drug: Gemcitabine, nab-Paclitaxel, GDC-0449

First Posted Date: 2010-03-17

Last Posted Date: 2019-04-26

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 98

Registration Number: NCT01088815

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Translational Genomics Research Institute (TGen), Scottsdale, Arizona, United States
🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx

Phase 2

Completed

Conditions: Squamous Cell Carcinoma of Oropharynx

Interventions: Radiation: IMRT
Drug: Cisplatin
Drug: Carboplatin

First Posted Date: 2010-03-17

Last Posted Date: 2022-11-08

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 60

Registration Number: NCT01088802

Locations: 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

A Trial of Boost Vaccinations of Pancreatic Tumor Cell Vaccine

Phase 2

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Biological: PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1 neo vaccine.

First Posted Date: 2010-03-17

Last Posted Date: 2024-08-06

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 71

Registration Number: NCT01088789

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Drug: Testosterone injection
Drug: Etoposide

First Posted Date: 2010-03-10

Last Posted Date: 2016-05-09

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 16

Registration Number: NCT01084759

Locations: 🇺🇸
Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites

Not Applicable

Terminated

Conditions: Malignant Ascites

Interventions: Device: Pleurx catheter
Procedure: paracentesis

First Posted Date: 2010-02-26

Last Posted Date: 2015-10-29

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 7

Registration Number: NCT01077063

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy